Tracey McCain
Compliance Officer bij BLUEPRINT MEDICINES CORPORATION
Vermogen: 6 M $ op 30-04-2024
Actieve functies van Tracey McCain
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Compliance Officer | 06-09-2016 | - |
| Algemeen Adviseur | 06-09-2016 | - | |
| Bedrijfssecretaris | 06-09-2016 | - | |
| KINIKSA PHARMACEUTICALS, LTD. | Directeur/Bestuurslid | 01-02-2018 | - |
| Independent Dir/Board Member | 01-02-2018 | - |
Loopbaan van Tracey McCain
Eerdere bekende functies van Tracey McCain
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMMUNOGEN, INC. | Directeur/Bestuurslid | 15-11-2021 | 12-02-2024 |
| Independent Dir/Board Member | 15-11-2021 | 12-02-2024 | |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Algemeen Adviseur | 01-01-2016 | 02-09-2016 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Algemeen Adviseur | 01-05-1997 | 01-09-2016 |
| Palmer & Dodge LLP | Corporate Officer/Principal | - | - |
Opleiding van Tracey McCain
| University of Pennsylvania | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
| Verenigd Koninkrijk | 2 |
Operationeel
| General Counsel | 3 |
| Director/Board Member | 2 |
| Independent Dir/Board Member | 2 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
| Palmer & Dodge LLP | Commercial Services |
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Beurs
- Insiders
- Tracey McCain
- Ervaring
